Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PRISM BioLab, Co. has entered into a drug discovery collaboration with Elix, Inc. The partnership will accelerate research on small molecule inhibitors of protein-protein interaction (PPI) targets by combining PRISM BioLab's proprietary peptide ...
read more
Dr. Havranek-Kosicek, previously Director of Finance and Control for the DSM Pharma Chemicals business unit of DSM Pharmaceutical Products, the pharmaceutical contract manufacturing and technology organization of Royal DSM N.V. (NYSE, Euronext: DSM ...
read more
As part of its CareCentered Contracting program Prime Therapeutics recently entered into an outcomes-based contract with Boehringer Ingelheim for Jardiance.
read more
Friday, December 01, 2017
Prime Therapeutics and Biogen have partnered on an outcomes-based contract for several MS drugs as part of Prime's CareCentered Contract program.
read more
Wednesday, March 02, 2016
WuXi Biologics Co. and Prima BioMed Ltd. have announced that through their strategic supply partnership, Prima's first-in-class immuno-oncology product candidate IMP321 (LAG-3 Ig fusion protein), manufactured at WuXi's state-of-the-art cGMP facility ...
read more
Wednesday, October 16, 2019
Prevail Therapeutics and Lonza announced the companies have entered into a strategic collaboration.
read more
Monday, September 25, 2017
Presage Biosciences announced the Mark Foundation’s first-ever award.
read more
Thursday, September 10, 2020
Presage Biosciences announced a new research collaboration with Takeda that will utilize CIVO to evaluate multiple investigational oncology agents and combinations in Phase 0 trials.
read more
As the number of next-generation oncology therapies in the clinical trial pipeline surges, Premier Research today announced three new oncology leadership team hires to strengthen the company’s expertise in the fast-growing areas of cell and gene ...
read more
Premier Research has added of Cassandra Matney, M.D., as Senior Medical Director.
read more
Tuesday, January 10, 2023
Premier Research and Centogene N.V. have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment, thereby ...
read more
Tuesday, January 09, 2024
Premier Research, a global leader in clinical research, product development, and consulting, has joined forces with BioCentriq, a Contract Development and Manufacturing Organization (CDMO), in a strategic partnership aimed at transforming the pre-...
read more
Premier Research announced the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) Leadership Team.
read more
Premier Research announced that it has acquired Health Decisions, a Durham, N.C.-based contract research organization (CRO) focused on clinical development in all areas of women’s health and diagnostics. Premier Research is a leading provider of ...
read more
Premier Research has acquired Camargo Pharmaceutical Services based in Cincinnati.
read more